The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Deficiency of the Humoral Immune Response to Measles Vaccine in Infants Immunized at Age 6 Months
Abstract
CONTEXT: Measles causes serious morbidity in infants, with the highest risk among those who are 6 to 12 months of age. In the United States, measles vaccine has been given at age 12 to 15 months to minimize interference by passive antibodies and to achieve the high seroprevalence required for herd immunity. Infants of mothers with vaccine-induced immunity may lose passively acquired antibodies before 12 months, leaving them susceptible to measles infection. OBJECTIVE: To assess the immunogenicity of measles vaccine in infants younger than 12 months. DESIGN: Cohort study conducted before and after measles immunization. SETTING: Pediatric clinic in Palo Alto, Calif. PARTICIPANTS: Infants 6 (n = 27), 9 (n = 26), and 12 (n = 34) months of age were enrolled; 72 provided both initial and follow-up samples. MAIN OUTCOME MEASURES: Evaluation of immunogenicity before and 12 weeks after measles vaccination, including measles neutralizing antibody titers, measles-specific T-cell proliferation, and cytokine profiles. RESULTS: Measles neutralizing antibodies were present before vaccination in 52% (12/23), 35% (7/20), and 0% (0/22) of 6-, 9-, and 12-month-old infants, respectively. In the absence of detectable passive antibodies, geometric mean titers after vaccination were significantly lower in 6-month-old infants compared with 9-month-old infants (27 vs 578, P = .01) and 12-month-old infants (27 vs 972, P=.001). The seroconversion rate, defined as a 4-fold rise in antibody titer, in these 6-month-old infants was only 67%, and only 36% of these infants achieved seroprotective neutralizing antibody titers of 120 or higher after vaccination compared with 100% of 9- and 12-month-old infants lacking detectable passive antibody prior to vaccination. T-cell proliferation and cytokine responses to measles did not differ with age. CONCLUSIONS: Humoral immunity was deficient in 6-month-old infants given measles vaccine, even in the absence of detectable passively acquired neutralizing antibodies. Comparison of their responses with those of 9- and 12-month-old infants indicates that a developmental maturation of the immune response to measles may occur during the first year of life, which affects the immunogenicity of measles vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Textbook of Pediatric Infectious Diseases
(2013) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/11900 · Cited by 1,758
Activation of human dendritic cells through CD40 cross-linking.
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., & Banchereau, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1263 · Cited by 1,317
Measles Antibody: Reevaluation of Protective Titers
Chen, R. T., Markowitz, L. E., Albrecht, P., Stewart, J. A., Mofenson, L. M., Preblud, S. R., & Orenstein, W. A. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.5.1036 · Cited by 608
Mechanism of Suppression of Cell-Mediated Immunity by Measles Virus
Karp, C. L., Wysocka, M., Wahl, L. M., Ahearn, J. M., Cuomo, P. J., Sherry, B., Trinchieri, G., & Griffin, D. E. (1996) · Science · doi:10.1126/science.273.5272.228 · Cited by 549
CD40 ligand-transduced co-stimulation of T cells in the development of helper function
Essen, D. V., Kikutani, H., & Gray, D. (1995) · Nature · doi:10.1038/378620a0 · Cited by 409
Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failure
Albrecht, P., Ennis, F. A., Saltzman, E. J., & Krugman, S. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)81021-4 · Cited by 374
Stuber, E., Strober, W., & Neurath, M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.693 · Cited by 338
Schmitt, E., Hoehn, P., Huels, C., Goedert, S., Palm, N., Rüde, E., & Germann, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240403 · Cited by 287
Differential CD4 T Cell Activation in Measles
Griffin, D. E., & Ward, B. J. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/168.2.275 · Cited by 218
Studies of human cord blood dendritic cells: evidence for functional immaturity
Hunt, D., Huppertz, H., Jiang, H., & Petty, R. (1994) · Blood · doi:10.1182/blood.v84.12.4333.bloodjournal84124333 · Cited by 189
Cited by
IgG placental transfer in healthy and pathological pregnancies
Palmeira, P., Quinello, C., Silveira-Lessa, A. L., Zago, C. A., & Carneiro-Sampaio, M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/985646 · Cited by 1,037
Factors That Influence the Immune Response to Vaccination
Zimmermann, P., & Curtis, N. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00084-18 · Cited by 939
B-cell responses to vaccination at the extremes of age
Siegrist, C.-A., & Aspinall, R. (2009) · Nature Reviews Immunology · doi:10.1038/nri2508 · Cited by 659
Neonatal and early life vaccinology
Siegrist, C.-A. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00028-7 · Cited by 593
Moss, W. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31463-0 · Cited by 530
Metadata
- Authors
- Gans, H. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1998-08-12
- Volume
- 280
- Issue
- 6
- Pages
- 527
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2079871630
- Cited by
- 278
- References
- 24
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deficiency of the Humoral Immune Response to Measles Vaccine in Infants Immunized at Age 6 Months. https://app.cochat.ai/papers/10.1001/jama.280.6.527
- The paper
- Gans, H. A. (1998). Deficiency of the Humoral Immune Response to Measles Vaccine in Infants Immunized at Age 6 Months. JAMA. https://doi.org/10.1001/jama.280.6.527
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.